Wellington Management Group LLP Deciphera Pharmaceuticals, Inc. Transaction History

Wellington Management Group LLP

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$13.58 - $17.36 $2.05 Million - $2.62 Million	150,873 New	150,873 $2.37 Million
Q4 2023 Feb 12, 2024	BUY	$10.11 - $16.54 $490,800 - $802,950	48,546 New	48,546 $783,000
Q1 2023 May 12, 2023	SELL	$14.26 - $22.1 $496,789 - $769,919	-34,838 Reduced 30.53%	79,289 $1.23 Million
Q4 2022 Feb 13, 2023	SELL	$14.85 - $19.04 $77,056 - $98,798	-5,189 Reduced 4.35%	114,127 $1.87 Million
Q3 2022 Nov 14, 2022	BUY	$12.38 - $20.23 $668,817 - $1.09 Million	54,024 Added 82.74%	119,316 $2.21 Million
Q2 2022 Aug 15, 2022	SELL	$9.11 - $13.98 $3,361 - $5,158	-369 Reduced 0.56%	65,292 $859,000
Q1 2022 May 16, 2022	SELL	$6.87 - $11.11 $1.1 Million - $1.78 Million	-159,940 Reduced 70.9%	65,661 $608,000
Q4 2021 Feb 11, 2022	BUY	$7.7 - $37.13 $190,305 - $917,667	24,715 Added 12.3%	225,601 $2.2 Million
Q3 2021 Nov 15, 2021	SELL	$26.46 - $37.15 $12,621 - $17,720	-477 Reduced 0.24%	200,886 $6.83 Million
Q2 2021 Aug 16, 2021	SELL	$32.73 - $47.95 $36,493 - $53,464	-1,115 Reduced 0.55%	201,363 $7.37 Million
Q1 2021 May 17, 2021	SELL	$40.39 - $56.73 $207,846 - $291,932	-5,146 Reduced 2.48%	202,478 $9.08 Million
Q4 2020 Feb 12, 2021	BUY	$51.77 - $66.18 $5.08 Million - $6.49 Million	98,054 Added 89.49%	207,624 $11.9 Million
Q3 2020 Nov 16, 2020	BUY	$43.8 - $58.16 $4.8 Million - $6.37 Million	109,570 New	109,570 $5.62 Million
Q1 2020 May 14, 2020	SELL	$33.63 - $69.4 $195,054 - $402,520	-5,800 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$31.7 - $69.93 $183,860 - $405,594	5,800 New	5,800 $361,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

Stay updated on Wellington Management Group LLP with notifications on news.